Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pain 3Neuralgia 3Breast Neoplasms 3Seizures 1Pinealoma 1Oligodendroglioma 1Obesity 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Myotoxicity 1Meningioma 1Medulloblastoma 1Lymphoma 1Inflammation 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Earache 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1Agnosia 1

Interventions

Ropivacaine 2Magnesium Sulfate 2Fentanyl 2trimebutine 3-thiocarbamoylbenzenesulfonate 1ramosetron 1Transdermal Patch 1Tablets 1Surveys and Questionnaires 1Psilocybin 1Pregabalin 1Nefopam 1Morphine 1Lidocaine 1Levobupivacaine 1Ketoprofen 1Ketamine 1Injections, Subcutaneous 1High-Energy Shock Waves 1Control Groups 1Capsaicin 1Bupivacaine 1Botulinum Toxins, Type A 1Anesthetics, Local 1Analgesics, Opioid 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Agnosia × Pregabalin × Clear all
NCT02024568 2013-12-31

Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia

Assaf-Harofeh Medical Center

Phase 2 Unknown
38 enrolled
Breast

Myotoxicity, Agnosia, Breast Neoplasms, Pain, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡